Gland Pharma Limited — Sodium Exporter Profile
Indian Pharmaceutical Exporter · #2 for Sodium · $11.4M export value · DGFT Verified
Gland Pharma Limited is the #2 Indian exporter of Sodium with $11.4M in export value and 229 verified shipments. Gland Pharma Limited holds a 3.2% market share in Sodium exports across 21 countries. The company exports 29 pharmaceutical products worth $262.0M across 15 therapeutic categories.
Gland Pharma Limited — Sodium Export Profile: Buyers & Destinations
Where Does India Export Sodium?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $120.1M | 2,402 | 57.4% |
| CANADA | $10.6M | 234 | 5.1% |
| KENYA | $8.3M | 335 | 4.0% |
| FRANCE | $8.1M | 188 | 3.9% |
| AUSTRALIA | $8.0M | 386 | 3.8% |
| TANZANIA | $7.0M | 140 | 3.3% |
| ETHIOPIA | $6.8M | 137 | 3.3% |
| NIGERIA | $6.7M | 153 | 3.2% |
| PHILIPPINES | $6.2M | 336 | 2.9% |
| BRAZIL | $5.5M | 111 | 2.7% |
India exports Sodium to 177 countries. The top destination is UNITED STATES (57.4%), followed by CANADA and KENYA.
Who Are the Top Buyers of Sodium from India?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CIPLA USA INC UPS SUPPLY CHAIN SOLU | UNITED STATES | $10.7M | 484 |
| UNICHEM PHARMACEUTICALS (USA) INC. | UNITED STATES | $7.0M | 140 |
| PLANET PHARMA | FRANCE | $5.8M | 115 |
| EUGIA US LLC | UNITED STATES | $4.5M | 91 |
| AIM RX 3PL, LLC | UNITED STATES | $3.6M | 73 |
| AUROLOGISTICS LLC (AUROMEDICS PHARM | UNITED STATES | $3.5M | 69 |
| AUROLOGISTIC LLC,(AUROMEDICS PHARMA | UNITED STATES | $3.4M | 68 |
| MINISTRY OF HEALTH | SEYCHELLES | $1.8M | 36 |
| RANBAXY FARMACEUTICA LTDA | BRAZIL | $1.6M | 33 |
| RANBAXY (THAILAND) CO., LTD. | THAILAND | $850.0K | 17 |
India's Sodium is purchased by 2,469 buyers worldwide. The top buyer is CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES), followed by UNICHEM PHARMACEUTICALS (USA) INC. and PLANET PHARMA.
What Is India's Total Sodium Export Value and How Much Does Gland Pharma Limited Contribute?
India exported $145.4M worth of Sodium through 15,000 shipments from 985 suppliers to 177 countries, serving 2,469 buyers globally. Gland Pharma Limited contributes $11.4M to this total, accounting for 3.2% of India's Sodium exports.
What Is the Average Shipment Value for Gland Pharma Limited's Sodium Exports?
Gland Pharma Limited's average Sodium shipment value is $50.0K per consignment, based on 229 shipments totaling $11.4M.
How Does Gland Pharma Limited Compare to Other Indian Sodium Exporters?
Gland Pharma Limited ranks #2 among 985 Indian Sodium exporters with a 3.2% market share. The top 3 exporters are CIPLA LIMITED ($22.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.4M), EUGIA PHARMA SPECIALITIES LIMITED ($13.6M). Gland Pharma Limited processed 229 shipments to 21 destination countries.
Regulatory Requirements: Exporting Sodium to Key Markets
What Gland Pharma Limited must comply with to export Sodium to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Gland Pharma Limited Compare to Nearest Sodium Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED | $13.6M | 271 | 2 | $50.0K |
| 5 | AUROBINDO PHARMA LTD | $13.2M | 341 | 10 | $38.8K |
| 2 | GLAND PHARMA LIMITED ★ | $11.4M | 229 | 21 | $50.0K |
| 6 | UNICHEM LABORATORIES LIMITED | $10.9M | 219 | 2 | $50.0K |
| 9 | TROIKAA PHARMACEUTICALS LIMITED | $10.2M | 235 | 27 | $43.5K |
Gland Pharma Limited ranks #2 among 985 Indian Sodium exporters. Average shipment value of $50.0K compared to the market average of $147.6K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Sodium Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,869 | 19.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,813 | 12.1% |
| DELHI AIR CARGO ACC (INDEL4) | 1,734 | 11.6% |
| JNPT | 844 | 5.6% |
| HYDERABAD ICD (INSNF6) | 804 | 5.4% |
| Bombay Air | 617 | 4.1% |
| AHEMDABAD ICD (INSBI6) | 445 | 3.0% |
| Delhi Air | 431 | 2.9% |
Geopolitical & Trade Policy Impact on Gland Pharma Limited's Sodium Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Gland Pharma. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the U.S. East Coast, necessitating strategic adjustments in logistics and pricing strategies. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (FTA), concluded on January 27, 2026, offers a favorable outlook. The agreement eliminates tariffs on most European optical, medical, surgical, and pharmaceutical exports to India, and vice versa, potentially enhancing Gland Pharma's competitiveness in the European market. This development aligns with the company's strategic objectives to deepen market penetration and increase market share within existing therapeutic areas. (en.wikipedia.org)
Gland Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Gland Pharma's export operations. The company's Visakhapatnam facility's recent EIR from the USFDA underscores its commitment to quality and regulatory adherence. (business-standard.com) Additionally, the Danish Medicines Agency's Good Manufacturing Practice (GMP) compliance certification for Gland Pharma's facility further validates its manufacturing excellence. (ainvest.com)
However, challenges persist, as evidenced by the French drug regulator ANSM's issuance of ten observations to Gland Pharma's subsidiary, Cenexi, following a GMP inspection. The company is actively addressing these observations, reflecting its proactive approach to regulatory compliance and continuous improvement. (business-standard.com)
About Gland Pharma Limited
Gland Pharma Limited exports 29 products worth $262.0M. Beyond Sodium, top products include Heparin, Enoxaparin, Syringe, Ketorolac, Ondansetron. View the complete Gland Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sodium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sodium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gland Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 177+ countries, 2,469+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sodium Export Data from Gland Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gland Pharma Limited's Sodium exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gland Pharma Limited
Full Company Profile →
29 products · $262.0M total trade · 15 categories
Sodium Stats
Company Overview
Top Products by Gland Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gland Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sodium. For current shipment-level data, contact TransData Nexus.